Remodelin, as a novel small molecule, has long been shown to reduce NAT10 activity11, thus avoiding mRNA acetylation, and has actually been demonstrated to get a good procedure for numerous varieties of tumors2. In our former study12, it was uncovered that Remodelin can inhibit the growth of OS by suppressing the expression of NAT10 in osteosarcoma